Polednak AP. Recent trends in incidence and mortality rates for leukemias, and in survival rates for childhood acute lymphocytic leukemia, in Upstate New York. Cancer. 1986 May 1; 57 (9):1850–1858.Recent trends in incidence and mortality rates for leukemias, and in survival rates for ...
Thus, the presence or absence of lymphoblasts with sheep erythrocyte receptors —a T-cell marker — distinguishes two forms of childhood acute lymphocytic leukemia, each with a distinct distribution of age and sex as well as other characteristic clinical features. (N Engl J Med 292: 828–832,...
Recently, Ingelfinger quoted the Director of the National Cancer Institute who said that "50 per cent of children with acute lymphocytic leukemia (who get) optimal treatment survive at least five years today. Tragically, only 15 per cent of the children afflicted get optimal treatment."1 In an...
Acute lymphocytic leukemia(ALL, also known as acute lymphoblastic leukemia) is the most common type of leukemia in children, but it can also affect adults. In this type of leukemia, immature lymphoid cells grow rapidly in the blood. It affects almost 6,000 people per year in the U.S. Acu...
Acute lymphoblastic leukemia (ALL) is a rare hematological malignancy. With the recent introduction of a classification system for hematopoietic and lymphoid neoplasms, more comprehensive assessment of ALL epidemiology is now possible. In this study, we describe recent international incidence of ALL and ...
Origin of Infection in Acute Nonlymphocytic Leukemia Stephen C. Schimpff Annals of Internal Medicine Nov 1972 CAS-1 JCR-Q1 SCIE 471 被引用 · 0 笔记 引用 Management of Adult Acute Myelogenous Leukaemia Derek CrowtherR PowlesChris Bateman...Ronald Bodley Scott BMJ Jan 1973 Consecutive adult pat...
Acute myeloid leukemia (AML) is a very heterogeneous and highly malignant blood cancer. Mutations of the DNA methyltransferase DNMT3A are among the most frequent recurrent genetic lesions in AML. The majority of DNMT3A-mutant AML patients shows fast rela
These scores were used to divide the test set patients into four quartiles that had strikingly disparate median survival rates of 3.9, 10.8, 11.1, and 13.6 years, respectively (Fig. 5-6B). The fact that tumor gene expression at the time of diagnosis predicts the length of survival implies ...
Flow Diagram of the Study Selection Process View LargeDownload ALL indicates acute lymphoblastic leukemia; MRD, measurable residual disease. Figure 2. Estimated Survival Curves, Stratified by Measurable Residual Disease (MRD) Status View LargeDownload Overall survival (OS) (A) and disease-free survival...
Survival of 839 chronic lymphocytic leukemia patients has been reviewed in relation to a number of patient and disease characteristics. Over all, the relative 5 yr survival rate was 44%. Studying survival by age and sex led to the following observations: Dividing age into intervals < 50, 50-...